中文字幕区,草莓视app下载安装旧版本,一个人看的www免费高清中文字幕,亚洲中文字幕无码永久免弗

产品详情

Edaravone

如果您对该产品感兴趣的话,可以
产品名称: Edaravone
产品型号: GOY-Y2065
产品展商: 谷研
产品文档: 无相关文档
发布时间:2023-04-26

简单介绍

Edaravone≥ 6.45mg/mL in DMSO, ≥ 47.8 mg/mL in EtOH with ultrasonic


Edaravone  的详细介绍

性能参数

产品名称

Edaravone

规格

10mM (in 1mL DMSO) 5mg 100mg

货号

GOY-Y2065

 含量

>98.00%

CAS

89-25-8

别名

 

 

 

化学名

5-methyl-2-phenyl-4H-pyrazol-3-one

分子式

C10H10N2O

分子量

分子 174.2

溶解度

≥ 6.45mg/mL in DMSO, ≥ 47.8 mg/mL in EtOH with ultrasonic

储存条件

Store at -20°C

General tips

 

用途

仅供科研

价格

电询

详细内容

Edaravone is a strong novel free radical scavenger, and inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.

Edaravone performs both preventative and therapeutic effects against toxicity of glutamate. Pretreatment of edaravone reduces the toxicity of glutamate towards SGNs. Edaravone reduces apoptosis and necrosis caused by glutamate. Pretreatment of edaravone (500 μM) reverses these changes to approximately normal levels. The protective effect of edaravone on SGNs against glutamate-induced apoptosis is associated with PI3K/Akt pathway and Bcl-2 protein family[4].

Edaravone exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Edaravone provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post-reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by edaravone pretreatment[1]. Edaravone significantly decreases infarct volume, with the average infarct volume in the edaravone-treated rats (227.6 mm3) being significantly lower than that in the control rats (264.0 mm3). Edaravone treatment also decreases the postischemic hemorrhage volumes (53.4 mm3 in edaravone-treated rats vs 176.4 mm3 in controls). In addition, the ratio of hemorrhage volume to infarct volume is lower in the edaravone-treated rats (23.5%) than in the untreated rats (63.2%)[2]. In edaravone (20 mg/kg)-treated rats, astrocyte activity (glial fibrillary acidic protein) and apoptotic cells (caspase-3) are decreased on the corpus callosum, germinal matrix, and cerebral cortex[3].

References:

[1]. Yoshida, H., et al. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev, 2006. 12(1): p. 9-20.

[2]. Okamura, K., et al. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia. Neurol Res, 2013.

[3]. Garcia CA, et al. Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus. Childs Nerv Syst. 2016 Dec 17. [Epub ahead of print]

[4]. Bai X, et al. Protective Effect of Edaravone on Glutamate-Induced Neurotoxicity in Spiral Ganglion Neurons. Neural Plast. 2016;2016:4034218. Epub 2016 Nov 10.

 

公司正在销售的产品:

1-**基硅烷-1-己炔 98%  N-羟基邻苯二甲酰亚胺 98%

O-(**基硅)羟胺 96%  硅藻土 CP

反式-3-(**基硅基)烯丙醇 97%  硅藻土G  TLC专用

3-**基硅氧基-1-丙炔 97%  硅藻土 TLC专用

**基硅乙酸酯 98%  一缩二丙二醇 99%

2-**硅基吡啶 97%  1,8-萘二甲酸酐 98%

ML-0305mg 10mg 25mg>98.00%Cas No. 1013750-77-0C20H20N4O4S

ML 3491mg 5mg 10mg>98.00%Cas No. 890819-86-0C23H22N2O4S2

MR-L2100mg 250mg 500mg>98.00%Cas No. N/AC19H16Cl3FN4O

Monoacetylphloroglucinol10mM (in 1mL DMSO) 10g 25g>98.00%Cas No. 480-66-0C8H8O4

ML-309 (hydrochloride)1mg 5mg 10mg>98.00%Cas No. 1355327-02-4C29H29FN4O2?HCl

N-Acetyl-S-allyl-L-cysteine1mg 5mg 10mg>98.00%Cas No. 23127-41-5C8H13NO3S

 


产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
Copyright@ 2003-2024  上海谷研实业有限公司  版权所有  
联系电话:021-39596320 021-39921927     

传真号码:021-39596320  021-39921927

QQ: 3004918891  3004905818    3004901493
移动电话:18321818584  15026555973
地址:上海松江新砖公路1155号

产品均为实验试剂,仅供科研实验使用,非药品、非食品、不可用于动物及人体!

         沪ICP备12048703号-32